Julius Maximilian Knerr

Julius Maximilian Knerr serves as a Guest Researcher in the Molecular and Translational Pharmacology section of the Department of Biomedical Sciences at the University of Copenhagen's Faculty of Health and Medical Sciences. His academic role focuses on elucidating viral receptor mechanisms with therapeutic applications for herpesvirus-related pathologies.

Dr. Knerr's research centers on virology and molecular pharmacology, specifically investigating G protein-coupled receptors (GPCRs) encoded by β- and γ-herpesviruses including Epstein-Barr virus (EBV). His work examines molecular properties of viral receptors like BILF1, their roles in immune evasion and oncogenesis, and potential targeting strategies for antiviral and anticancer therapies. This integrates structural biology, viral pathogenesis, and translational drug development to address herpesvirus-associated diseases.

Analysis of his 2021-2022 publications reveals consistent specialization in herpesviral GPCR systems. His reviews systematically analyze structural characteristics and functional mechanisms of receptors such as BILF1, highlighting their significance in viral immune modulation and cancer progression. This research trajectory demonstrates strong interdisciplinary convergence between virology, oncology, and pharmacological targeting, positioning his work at the forefront of developing novel therapeutics against herpesvirus-related malignancies and infections.